| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Knee Joint | 2 | 2017 | 194 | 1.16 | Why? |
| Osteoarthritis, Knee | 2 | 2017 | 158 | 1.11 | Why? |
| Shoulder Pain | 2 | 2019 | 36 | 0.94 | Why? |
| Decompression, Surgical | 2 | 2019 | 114 | 0.89 | Why? |
| Evidence-Based Medicine | 8 | 2020 | 3228 | 0.85 | Why? |
| Fracture Healing | 2 | 2017 | 37 | 0.84 | Why? |
| Ultrasonic Therapy | 2 | 2017 | 43 | 0.82 | Why? |
| Shoulder Impingement Syndrome | 1 | 2019 | 6 | 0.80 | Why? |
| Practice Guidelines as Topic | 15 | 2020 | 15421 | 0.70 | Why? |
| Ultrasonic Waves | 1 | 2017 | 32 | 0.68 | Why? |
| Arthroscopy | 1 | 2017 | 46 | 0.67 | Why? |
| Conflict of Interest | 1 | 2018 | 175 | 0.60 | Why? |
| Conservative Treatment | 1 | 2017 | 349 | 0.53 | Why? |
| Patient Reported Outcome Measures | 1 | 2017 | 912 | 0.44 | Why? |
| Randomized Controlled Trials as Topic | 18 | 2021 | 10649 | 0.43 | Why? |
| Adrenal Cortex Hormones | 4 | 2020 | 6537 | 0.40 | Why? |
| Oxygen Inhalation Therapy | 2 | 2020 | 3629 | 0.39 | Why? |
| Vasoconstrictor Agents | 3 | 2017 | 714 | 0.37 | Why? |
| Pregnancy Complications, Cardiovascular | 1 | 2012 | 231 | 0.37 | Why? |
| Publishing | 1 | 2019 | 990 | 0.37 | Why? |
| Decision Making | 4 | 2019 | 3132 | 0.36 | Why? |
| Occult Blood | 3 | 2019 | 275 | 0.36 | Why? |
| Decision Support Systems, Clinical | 3 | 2018 | 551 | 0.36 | Why? |
| Aerosols | 2 | 2021 | 5393 | 0.34 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.32 | Why? |
| Sigmoidoscopy | 3 | 2019 | 50 | 0.30 | Why? |
| Foramen Ovale, Patent | 2 | 2018 | 153 | 0.30 | Why? |
| Colonoscopy | 3 | 2019 | 738 | 0.28 | Why? |
| Early Detection of Cancer | 4 | 2019 | 1956 | 0.27 | Why? |
| Platelet Aggregation Inhibitors | 3 | 2018 | 1671 | 0.26 | Why? |
| Pharyngitis | 2 | 2017 | 687 | 0.25 | Why? |
| Decision Support Techniques | 3 | 2018 | 903 | 0.24 | Why? |
| Norway | 4 | 2019 | 1004 | 0.23 | Why? |
| Checklist | 2 | 2018 | 714 | 0.23 | Why? |
| Colorectal Neoplasms | 3 | 2019 | 1884 | 0.22 | Why? |
| Triage | 1 | 2020 | 7151 | 0.22 | Why? |
| Quality of Life | 4 | 2019 | 9820 | 0.21 | Why? |
| Fibrinolytic Agents | 1 | 2012 | 1702 | 0.21 | Why? |
| Carrageenan | 1 | 2021 | 123 | 0.20 | Why? |
| Pain Measurement | 3 | 2018 | 533 | 0.20 | Why? |
| Rotator Cuff | 1 | 2019 | 15 | 0.20 | Why? |
| Chemoprevention | 2 | 2021 | 585 | 0.19 | Why? |
| Thrombophilia | 1 | 2012 | 1935 | 0.19 | Why? |
| Chronic Pain | 2 | 2018 | 736 | 0.19 | Why? |
| Shoulder | 1 | 2019 | 96 | 0.19 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.19 | Why? |
| Brain Ischemia | 3 | 2018 | 2813 | 0.18 | Why? |
| Shock, Traumatic | 1 | 2017 | 18 | 0.18 | Why? |
| Transcatheter Aortic Valve Replacement | 2 | 2017 | 839 | 0.18 | Why? |
| Analgesics, Opioid | 2 | 2018 | 1070 | 0.18 | Why? |
| Embolic Protection Devices | 1 | 2017 | 16 | 0.18 | Why? |
| Spinal Puncture | 1 | 2018 | 95 | 0.17 | Why? |
| Stroke | 5 | 2018 | 8839 | 0.17 | Why? |
| Needles | 1 | 2018 | 87 | 0.17 | Why? |
| Nutritional Requirements | 1 | 2018 | 115 | 0.17 | Why? |
| Quality Improvement | 3 | 2020 | 2435 | 0.17 | Why? |
| Tibial Fractures | 1 | 2017 | 32 | 0.17 | Why? |
| Prostate-Specific Antigen | 1 | 2018 | 213 | 0.17 | Why? |
| Ezetimibe | 1 | 2017 | 50 | 0.17 | Why? |
| Glucagon-Like Peptide 1 | 1 | 2017 | 83 | 0.16 | Why? |
| Incretins | 1 | 2017 | 61 | 0.16 | Why? |
| Adenoma | 1 | 2019 | 215 | 0.16 | Why? |
| Data Display | 1 | 2017 | 74 | 0.16 | Why? |
| Intracranial Embolism | 1 | 2017 | 73 | 0.16 | Why? |
| Shock, Hemorrhagic | 1 | 2017 | 81 | 0.16 | Why? |
| Carcinoma | 1 | 2019 | 256 | 0.16 | Why? |
| Fluid Therapy | 2 | 2017 | 628 | 0.15 | Why? |
| Prosthesis Failure | 1 | 2017 | 195 | 0.15 | Why? |
| Humans | 55 | 2021 | 930598 | 0.15 | Why? |
| Disease | 1 | 2017 | 126 | 0.15 | Why? |
| Abscess | 1 | 2018 | 234 | 0.15 | Why? |
| Societies, Medical | 1 | 2012 | 6907 | 0.15 | Why? |
| Insurance, Health, Reimbursement | 1 | 2017 | 205 | 0.14 | Why? |
| Secondary Prevention | 3 | 2018 | 762 | 0.14 | Why? |
| Resuscitation | 2 | 2017 | 638 | 0.14 | Why? |
| Mass Screening | 3 | 2019 | 8005 | 0.14 | Why? |
| Comprehension | 1 | 2018 | 259 | 0.14 | Why? |
| Epinephrine | 1 | 2017 | 323 | 0.14 | Why? |
| Anti-HIV Agents | 2 | 2017 | 2209 | 0.14 | Why? |
| Cannula | 1 | 2020 | 750 | 0.14 | Why? |
| Ischemic Attack, Transient | 1 | 2018 | 439 | 0.14 | Why? |
| Consumer Behavior | 2 | 2018 | 544 | 0.13 | Why? |
| Choice Behavior | 1 | 2017 | 319 | 0.13 | Why? |
| Early Termination of Clinical Trials | 1 | 2017 | 1256 | 0.13 | Why? |
| Hypotension | 1 | 2017 | 392 | 0.13 | Why? |
| Physicians, Primary Care | 1 | 2017 | 298 | 0.13 | Why? |
| Venous Thromboembolism | 1 | 2012 | 4273 | 0.13 | Why? |
| Network Meta-Analysis | 3 | 2020 | 426 | 0.13 | Why? |
| Observational Studies as Topic | 2 | 2017 | 1887 | 0.12 | Why? |
| Oropharynx | 1 | 2021 | 1581 | 0.12 | Why? |
| Surgical Wound Infection | 1 | 2018 | 501 | 0.12 | Why? |
| Bias | 1 | 2018 | 1109 | 0.12 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2017 | 436 | 0.12 | Why? |
| Brain Injuries | 1 | 2017 | 374 | 0.11 | Why? |
| Terminology as Topic | 1 | 2017 | 546 | 0.11 | Why? |
| Ivermectin | 1 | 2021 | 973 | 0.11 | Why? |
| Heart Valve Prosthesis | 1 | 2017 | 533 | 0.11 | Why? |
| Fractures, Bone | 1 | 2017 | 487 | 0.11 | Why? |
| Anticoagulants | 3 | 2018 | 9563 | 0.11 | Why? |
| Meta-Analysis as Topic | 1 | 2018 | 1289 | 0.11 | Why? |
| Aortic Valve | 1 | 2017 | 664 | 0.11 | Why? |
| World Health Organization | 2 | 2021 | 4213 | 0.10 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.10 | Why? |
| Patient Participation | 1 | 2017 | 829 | 0.10 | Why? |
| Research Design | 3 | 2021 | 5830 | 0.10 | Why? |
| Drug Monitoring | 1 | 2017 | 1408 | 0.09 | Why? |
| Aortic Valve Stenosis | 1 | 2017 | 741 | 0.09 | Why? |
| Hydroxychloroquine | 3 | 2021 | 12447 | 0.09 | Why? |
| Patient-Centered Care | 1 | 2017 | 860 | 0.09 | Why? |
| Activities of Daily Living | 1 | 2017 | 1530 | 0.09 | Why? |
| Pain Management | 1 | 2017 | 854 | 0.09 | Why? |
| Guideline Adherence | 2 | 2020 | 2309 | 0.09 | Why? |
| Trust | 1 | 2019 | 1487 | 0.09 | Why? |
| Clinical Decision-Making | 2 | 2021 | 3755 | 0.09 | Why? |
| Child Health | 1 | 2017 | 940 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 2 | 2017 | 3776 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.08 | Why? |
| Abortion, Spontaneous | 1 | 2012 | 776 | 0.08 | Why? |
| Adenosine Monophosphate | 2 | 2020 | 5652 | 0.08 | Why? |
| Alanine | 2 | 2020 | 5687 | 0.08 | Why? |
| Prostatic Neoplasms | 1 | 2018 | 1637 | 0.08 | Why? |
| Antiphospholipid Syndrome | 1 | 2012 | 533 | 0.07 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 1510 | 0.07 | Why? |
| Opioid-Related Disorders | 1 | 2017 | 1185 | 0.07 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.07 | Why? |
| Treatment Outcome | 7 | 2021 | 51732 | 0.07 | Why? |
| Attitude to Health | 1 | 2017 | 2002 | 0.07 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.07 | Why? |
| Pregnant Women | 1 | 2017 | 2535 | 0.07 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.06 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2017 | 5164 | 0.06 | Why? |
| Education, Medical, Graduate | 1 | 2017 | 2082 | 0.06 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2012 | 1731 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2018 | 3361 | 0.06 | Why? |
| Models, Statistical | 1 | 2019 | 5312 | 0.06 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.06 | Why? |
| HIV Infections | 2 | 2017 | 11620 | 0.06 | Why? |
| Pregnancy Complications, Infectious | 2 | 2017 | 11559 | 0.06 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.05 | Why? |
| Skin Diseases | 1 | 2018 | 2509 | 0.05 | Why? |
| Comparative Effectiveness Research | 1 | 2020 | 178 | 0.05 | Why? |
| Uncertainty | 2 | 2021 | 1888 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.05 | Why? |
| Attitude of Health Personnel | 1 | 2018 | 4741 | 0.05 | Why? |
| Antidepressive Agents, Tricyclic | 1 | 2018 | 29 | 0.05 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.05 | Why? |
| Epidemiologic Studies | 1 | 2021 | 554 | 0.05 | Why? |
| Heparin | 1 | 2012 | 2600 | 0.05 | Why? |
| Recurrence | 2 | 2018 | 3675 | 0.05 | Why? |
| Post-Dural Puncture Headache | 1 | 2018 | 33 | 0.04 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.04 | Why? |
| Current Procedural Terminology | 1 | 2017 | 10 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Lower Urinary Tract Symptoms | 1 | 2018 | 116 | 0.04 | Why? |
| Pregnancy | 3 | 2017 | 23879 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.04 | Why? |
| Ethics, Research | 1 | 2020 | 328 | 0.04 | Why? |
| Critical Illness | 2 | 2018 | 17281 | 0.04 | Why? |
| Cannabinoids | 1 | 2018 | 134 | 0.04 | Why? |
| Tonsillitis | 1 | 2017 | 67 | 0.04 | Why? |
| Peer Review | 1 | 2018 | 204 | 0.04 | Why? |
| Internship and Residency | 1 | 2017 | 4987 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Clinical Medicine | 1 | 2017 | 93 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.04 | Why? |
| Arterial Pressure | 1 | 2017 | 208 | 0.04 | Why? |
| Diabetic Angiopathies | 1 | 2017 | 146 | 0.04 | Why? |
| Random Allocation | 1 | 2018 | 773 | 0.04 | Why? |
| Anticholesteremic Agents | 1 | 2017 | 186 | 0.03 | Why? |
| Lebanon | 1 | 2017 | 557 | 0.03 | Why? |
| Prosthesis Design | 1 | 2017 | 594 | 0.03 | Why? |
| Drainage | 1 | 2018 | 414 | 0.03 | Why? |
| Female | 8 | 2019 | 380317 | 0.03 | Why? |
| Costs and Cost Analysis | 1 | 2018 | 694 | 0.03 | Why? |
| Vomiting | 1 | 2018 | 722 | 0.03 | Why? |
| Oximetry | 1 | 2018 | 658 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2018 | 657 | 0.03 | Why? |
| Anticonvulsants | 1 | 2018 | 634 | 0.03 | Why? |
| Standard of Care | 1 | 2020 | 1297 | 0.03 | Why? |
| Patient Outcome Assessment | 1 | 2017 | 707 | 0.03 | Why? |
| Data Accuracy | 1 | 2018 | 715 | 0.03 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.03 | Why? |
| Internal Medicine | 1 | 2017 | 557 | 0.03 | Why? |
| Postpartum Period | 1 | 2017 | 936 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Adult | 5 | 2019 | 244371 | 0.03 | Why? |
| Risk Factors | 3 | 2017 | 71621 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2019 | 17020 | 0.03 | Why? |
| Exercise Therapy | 1 | 2019 | 976 | 0.02 | Why? |
| Postoperative Complications | 2 | 2019 | 5861 | 0.02 | Why? |
| Male | 6 | 2019 | 367725 | 0.02 | Why? |
| General Practitioners | 1 | 2017 | 568 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2021 | 1766 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Safety Management | 1 | 2017 | 1093 | 0.02 | Why? |
| Switzerland | 1 | 2017 | 2738 | 0.02 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Aged | 6 | 2019 | 215776 | 0.02 | Why? |
| Incidence | 2 | 2019 | 25622 | 0.02 | Why? |
| Equipment Design | 1 | 2018 | 3095 | 0.02 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.02 | Why? |
| Dexamethasone | 1 | 2017 | 2055 | 0.02 | Why? |
| Survival Analysis | 1 | 2019 | 7592 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.02 | Why? |
| Internationality | 1 | 2018 | 3297 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
| Oxygen | 1 | 2018 | 3715 | 0.02 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.02 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.02 | Why? |
| Middle Aged | 5 | 2019 | 270681 | 0.02 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.02 | Why? |
| Canada | 1 | 2017 | 6018 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Germany | 1 | 2017 | 9196 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2019 | 5002 | 0.01 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.01 | Why? |
| Models, Theoretical | 1 | 2017 | 6659 | 0.01 | Why? |
| Spain | 1 | 2017 | 15545 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2017 | 88759 | 0.01 | Why? |
| United Kingdom | 1 | 2017 | 18046 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Public Health | 1 | 2017 | 16359 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Retrospective Studies | 1 | 2017 | 105322 | 0.00 | Why? |